The CT Colonography (CTC) Coalition has called on the U.S. Preventive Services Task Force (USPSTF) to reconsider its recommendation regarding virtual colorectal cancer screening, following the statement issued by the task force maintaining that further research is still required to make a conclusive recommendation regarding CTC.
Immunomedics and GE Healthcare have entered into a license and collaboration agreement for the evaluation of labeling technologies based on Immunomedics' patented F-18 peptide labeling method.
CT colonography (CTC), or virtual colonoscopy, is not cost-effective if reimbursed at the same rate as colonoscopy, based on a study published online July 27 in the Journal of the National Cancer Institute. However, the accompanying editorial noted that cost-effectiveness analyses are useful, but that they often cannot include some important considerations.
Patients who have previously refused colorectal cancer screening are willing to undergo CT colonography (CTC), or virtual colonoscopy, but are not willing to pay for the exam themselves when not covered by insurance, according to a study in the August issue of the American Journal of Roentgenology.
New health insurance plans or insurance policies beginning on or after Sept. 23 will be required to cover, without cost sharing, several recommended preventive healthcare services--including breast cancer screening--under the Patient Protection and Affordable Care Act.
Surveillance colonoscopy is cost-effective for patients at high risk for developing colorectal cancer, but aggressive surveillance is costly and less effective for low-risk patients, according to a study published online June 21 in Gastroenterology.
Major pathologic response to preoperative chemotherapy and radiation occurs in a minority of patients with pancreatic adenocarcinoma and is independently associated with prolonged survival, according to a study presented at the 46th annual meeting of the American Society of Clinical Oncology (ASCO) on June 6 in Chicago.
Until the development of biomarkers indicative of histology, polyp size will continue to be the most important biomarker for determining management of colonic polyps found at screening and diagnostic CT colonography (CTC), according to a review in this month’s Radiology.
PET combined with CT colonography (CTC) may provide a suitable alternative for detecting polyps and cancer in the colon, and the lack of bowel prep might be particularly beneficial in the elderly population, a study published in the June issue of the Journal of Nuclear Medicine shows.
The American College of Radiology (ACR) is urging Congress to pass the Virtual Screening for Colorectal Cancer Act of 2010 (H.R. 5461) which would require the Centers for Medicare & Medicaid Services (CMS) to provide coverage of screening CT colonography, or virtual colonoscopy, to Medicare beneficiaries.
The adenomatous lesion detection rate is an independent predictor of the risk of interval colorectal cancer after screening colonoscopy, according to the findings of a recent study published in the May edition of the New England Journal of Medicine.
The use of combined PET/CT can confirm a suspected colorectal cancer recurrence at an early stage, helping significantly in treatment planning and improved targeted patient care, according to a study presented May 5 at the American Roentgen Ray Society (ARRS) annual meeting in San Diego.
Limited-preparation, low-dose CT colonography is a useful minimally invasive option to evaluate the colon of elderly patients who are medically unfit or unsuitable for colonoscopy, according to a study published in the May issue of the American Journal of Roentgenology.
Based on a study in the April 28 issue of the Journal of the American Medical Association, the use of diagnostic imaging studies in cancer patients covered by Medicare is growing--with the use of PET imaging most significantly increasing--and costs for this patient population are growing at twice the rate of the overall costs of cancer care. However, while imaging costs are increasing, as of 2006 these costs still made up less than 6 percent of the overall healthcare costs for cancer patients, the study's lead author Michaela A. Dinan, BS, said in an interview.
Hybridyne Imaging Technologies in Toronto has received FDA 510(k) clearance to market ProxiScan, a gamma camera for the detection of cancer and other abnormalities in the body.
A study in the April issue of Radiology has found that one out of every 200 asymptomatic people who have been screened with virtual colonoscopy has a clinically unsuspected malignant cancer, and that half of those cancers were located outside of the colon.
A lower follow-up exam rate for screen-detected colorectal abnormalities was noted among African-American individuals when compared with Caucasian individuals, and healthcare utilization may be to blame instead of biology in regard to the colorectal cancer racial disparity, according to a study published online this month in the Journal of National Cancer Institute.
The use of CT colonography is useful—and safe—for a preoperative exam of the proximal colon in patients who have been treated with metallic stents due to colon obstruction caused by colorectal cancer, according to a study published in the March issue of Radiology.
Written by Staff Report
CTC safe & effective for elderlyCT colonography (CTC), or virtual colonoscopy, is a safe and effective screening modality for the older patient population in the screening of colorectal cancer, according to a retrospective analysis published in the February issue of Radiology.
A new technique called personalized analysis of rearranged ends provides an accurate and specific way to monitor tumors by identifying personalized biomarkers from tumor DNA, according to a study published in the Feb. 24 issue of Science Translational Medicine.
|